Liwei Dong

4.2k total citations · 1 hit paper
102 papers, 3.2k citations indexed

About

Liwei Dong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Liwei Dong has authored 102 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 30 papers in Cancer Research and 25 papers in Surgery. Recurrent topics in Liwei Dong's work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (9 papers). Liwei Dong is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (9 papers). Liwei Dong collaborates with scholars based in China, United States and Hong Kong. Liwei Dong's co-authors include Hongyang Wang, Yexiong Tan, Yufei Pan, Tianyi Jiang, Lihui Xie, Xiuxing Liu, Jinguo Ye, Depeng Wang, Wenru Su and Xiaopeng Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

In The Last Decade

Liwei Dong

99 papers receiving 3.1k citations

Hit Papers

Immune cell profiling of COVID-19 patients in the recover... 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing
    2020 524 citations Liwei Dong, Hongyang Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liwei Dong China 35 1.6k 686 546 440 425 102 3.2k
Xiaojing Wang China 31 1.3k 0.8× 664 1.0× 616 1.1× 256 0.6× 154 0.4× 107 2.9k
Yili Wang China 27 862 0.5× 368 0.5× 550 1.0× 690 1.6× 237 0.6× 121 2.7k
Bruno Galy Germany 36 2.5k 1.6× 716 1.0× 364 0.7× 337 0.8× 179 0.4× 63 7.2k
Wenli Liu China 33 1.5k 0.9× 463 0.7× 683 1.3× 353 0.8× 165 0.4× 168 3.2k
Tianmin Xu China 27 1.3k 0.8× 623 0.9× 372 0.7× 370 0.8× 492 1.2× 96 2.6k
Jian Tu China 32 2.3k 1.4× 1.6k 2.3× 306 0.6× 257 0.6× 236 0.6× 118 4.1k
Junchao Cai China 33 2.4k 1.5× 1.4k 2.1× 487 0.9× 532 1.2× 219 0.5× 74 3.8k
Baharia Mograbi France 39 2.1k 1.3× 712 1.0× 560 1.0× 642 1.5× 190 0.4× 106 4.1k
Yingxin Zhao United States 34 1.9k 1.1× 337 0.5× 470 0.9× 353 0.8× 163 0.4× 86 3.0k
Hua Yang China 37 1.9k 1.2× 685 1.0× 597 1.1× 734 1.7× 124 0.3× 179 4.1k

Countries citing papers authored by Liwei Dong

Since Specialization
Citations

This map shows the geographic impact of Liwei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Dong more than expected).

Fields of papers citing papers by Liwei Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Dong. The network helps show where Liwei Dong may publish in the future.

Co-authorship network of co-authors of Liwei Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Dong. A scholar is included among the top collaborators of Liwei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Dong. Liwei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jingkai, Liwei Dong, Yun Ke, et al.. (2025). Ultrasensitive biodegradable piezoelectric sensors with localized stress concentration strategy for real-time physiological monitoring. Chemical Engineering Journal. 507. 160521–160521. 9 indexed citations
2.
Montgomery, Magdalene K., Sihan Lin, Zixi Cheng, et al.. (2025). HEXA-FC protein therapy increases skeletal muscle glucose uptake and improves glycaemic control in mice with insulin resistance and in a mouse model of type 2 diabetes. Diabetologia. 68(7). 1530–1543. 1 indexed citations
3.
Dong, Liwei, et al.. (2025). Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective. Annals of Medicine. 57(1). 2565437–2565437.
4.
Zeng, Tianmei, Tianyi Jiang, Guang Yang, et al.. (2024). Bortezomib in previously treated phosphatase and tension homology‐deficient patients with advanced intrahepatic cholangiocarcinoma: An open‐label, prospective and single‐centre phase II trial. Clinical and Translational Medicine. 14(5). e1675–e1675. 4 indexed citations
5.
Pan, Yufei, Lin Zhong, Min Wang, et al.. (2024). PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma. Phytomedicine. 131. 155790–155790. 1 indexed citations
6.
Li, Xin, Yufei Pan, Yibin Chen, et al.. (2024). Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma. Cell Death and Disease. 15(4). 300–300. 28 indexed citations
7.
Jiang, Tianyi, et al.. (2023). Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases. Genes & Diseases. 11(4). 100996–100996. 5 indexed citations
8.
Dou, Wei‐Tao, Yuanyuan Shi, Ling Zhu, et al.. (2023). Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of Liver Cancer. Journal of the American Chemical Society. 145(31). 17377–17388. 19 indexed citations
9.
Yu, Yi, Mingjie Zhu, Jie Yang, et al.. (2022). Age-related differential gene expression in granulosa cells and its effects on fertility using high-throughput transcriptomics. Systems Biology in Reproductive Medicine. 68(3). 190–202. 3 indexed citations
10.
Jiang, Tianyi, Yuanyuan Shi, Xiaoqiang Cui, et al.. (2022). PTEN Deficiency Facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis. Gastroenterology. 164(3). 424–438. 59 indexed citations
11.
12.
Pan, Jie, et al.. (2021). Autophagy participants in the dedifferentiation of mouse 3T3-L1 adipocytes triggered by hypofunction of insulin signaling. Cellular Signalling. 80. 109911–109911. 10 indexed citations
13.
Jiang, Tianyi, Yuanyuan Shi, Yufei Pan, et al.. (2019). RPB5‐Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding. Hepatology. 71(6). 2005–2022. 20 indexed citations
14.
Wang, Yuefang, Liwei Dong, & Yuying Liu. (2019). Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 34(8). 529–536. 17 indexed citations
15.
Dong, Liwei, et al.. (2015). Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1. OncoTargets and Therapy. 8. 3649–3649. 49 indexed citations
16.
Tang, Liang, Yexiong Tan, Bei‐Ge Jiang, et al.. (2013). The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma. Clinical Cancer Research. 19(8). 2014–2024. 51 indexed citations
17.
18.
Sun, Wen, Jin Ding, Kun Wu, et al.. (2011). Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology. 54(4). 1259–1272. 48 indexed citations
19.
Dong, Liwei. (2010). The Study of Anti-bradycardic Effect and Mechanism of Ganfu Granule in Rats. Zhongguo shiyan fangjixue zazhi. 1 indexed citations
20.
Kong, Xiaoni, He‐Xin Yan, Lei Chen, et al.. (2007). LPS-induced down-regulation of signal regulatory protein α contributes to innate immune activation in macrophages. The Journal of Experimental Medicine. 204(11). 2719–2731. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojing Wang Breakdown of academic impact, for papers by Yili Wang Breakdown of academic impact, for papers by Bruno Galy Breakdown of academic impact, for papers by Wenli Liu Breakdown of academic impact, for papers by Tianmin Xu Breakdown of academic impact, for papers by Jian Tu Breakdown of academic impact, for papers by Junchao Cai Breakdown of academic impact, for papers by Baharia Mograbi Breakdown of academic impact, for papers by Yingxin Zhao Breakdown of academic impact, for papers by Hua Yang
Rankless by CCL
2026